Streetbeat News

HLMAF

Halma plc

https://www.halma.com/

CEO

Andrew Williams

Industry

Electromedical and Electrotherapeutic Apparatus Manufacturing

Open

36.00

Mkt cap

13B

Volume

100

High

36.00

P/E Ratio

37.03

52-wk high

36.21

Low

35.18

Div yield

0.01

52-wk low

26.82

Halma plc (HLMAF) held its Q3 2024 earnings call, presenting strong half-year results. The call included participation from major financial institutions such as UBS, Barclays, and Morgan Stanley.

Portfolio Pulse from

November 22, 2024 | 7:15 pm

Halma PLC reported record first-half results with a 13% increase in revenue to £1.07 billion and a 17% rise in adjusted pre-tax profit to £222.5 million. The company also announced a dividend hike, leading to a nearly 10% jump in its share price.

Portfolio Pulse from

November 21, 2024 | 9:15 am

Halma PLC has acquired French surgical tools maker Lamidey Noury Medical for €50 million, enhancing its healthcare division. Lamidey Noury specializes in devices for minimally invasive surgeries across various medical fields.

Portfolio Pulse from

November 18, 2024 | 9:30 am

Halma PLC is expected to report steady growth in its upcoming half-year results, with organic revenue growth, operating margin expansion, and strong cash generation. The company's share price has remained flat over the past six months.

Portfolio Pulse from

November 15, 2024 | 10:30 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.